Meridian Bioscience Current Ratio 2006-2019 | VIVO

Meridian Bioscience current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Meridian Bioscience Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.14B $0.02B 6.93
2019-03-31 $0.15B $0.02B 6.01
2018-12-31 $0.14B $0.02B 6.75
2018-09-30 $0.14B $0.02B 5.75
2018-06-30 $0.14B $0.02B 5.73
2018-03-31 $0.14B $0.03B 5.41
2017-12-31 $0.14B $0.02B 5.82
2017-09-30 $0.13B $0.02B 5.85
2017-06-30 $0.13B $0.02B 6.47
2017-03-31 $0.13B $0.02B 6.47
2016-12-31 $0.13B $0.02B 5.99
2016-09-30 $0.13B $0.02B 5.62
2016-06-30 $0.13B $0.02B 6.27
2016-03-31 $0.13B $0.02B 6.03
2015-12-31 $0.12B $0.02B 7.83
2015-09-30 $0.12B $0.02B 7.83
2015-06-30 $0.12B $0.01B 8.88
2015-03-31 $0.12B $0.02B 7.65
2014-12-31 $0.12B $0.02B 7.88
2014-09-30 $0.11B $0.01B 8.21
2014-06-30 $0.11B $0.02B 6.70
2014-03-31 $0.11B $0.02B 6.39
2013-12-31 $0.11B $0.02B 6.36
2013-09-30 $0.11B $0.02B 5.82
2013-06-30 $0.11B $0.02B 5.51
2013-03-31 $0.10B $0.02B 5.85
2012-12-31 $0.09B $0.02B 4.91
2012-09-30 $0.10B $0.02B 5.23
2012-06-30 $0.09B $0.02B 5.35
2012-03-31 $0.09B $0.02B 5.65
2011-12-31 $0.09B $0.02B 5.40
2011-09-30 $0.09B $0.02B 5.92
2011-06-30 $0.09B $0.02B 5.39
2011-03-31 $0.09B $0.02B 5.53
2010-12-31 $0.10B $0.02B 5.44
2010-09-30 $0.10B $0.02B 6.56
2010-06-30 $0.11B $0.01B 9.25
2010-03-31 $0.11B $0.01B 8.91
2009-12-31 $0.12B $0.01B 8.63
2009-09-30 $0.12B $0.02B 6.99
2009-06-30 $0.10B $0.01B 8.40
2009-03-31 $0.10B $0.01B 8.02
2008-12-31 $0.10B $0.01B 7.67
2008-09-30 $0.10B $0.02B 6.19
2008-06-30 $0.09B $0.01B 6.57
2008-03-31 $0.09B $0.02B 5.76
2007-12-31 $0.10B $0.02B 6.17
2007-09-30 $0.09B $0.02B 5.49
2007-06-30 $0.09B $0.01B 6.48
2007-03-31 $0.08B $0.02B 5.51
2006-12-31 $0.08B $0.02B 4.45
2006-09-30 $0.08B $0.02B 3.92
2006-06-30 $0.08B $0.02B 4.51
2006-03-31 $0.07B $0.01B 4.83
2005-12-31 $0.07B $0.02B 3.93
2005-09-30 $0.07B $0.02B 3.55
2005-06-30 $0.04B $0.02B 1.85
2005-03-31 $0.04B $0.02B 1.87
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.419B $0.214B
Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. In addition, the company develops and manufactures a variety of biological and non-biological materials used in proficiency testing programs. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Meridian Bioscience designs their products to enhance the well-being of the patient-while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $150.600B 28.31
Medtronic (MDT) Ireland $148.093B 20.79
Stryker (SYK) United States $82.318B 28.47
Boston Scientific (BSX) United States $58.839B 28.54
Baxter (BAX) United States $44.837B 27.19
EssilorLuxottica Societe Anonyme (ESLOY) France $31.126B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.280B 18.74
Lonza Group Ag (LZAGY) Switzerland $25.580B 0.00
Coloplast (CLPBY) Denmark $25.337B 40.45
Terumo (TRUMY) Japan $21.867B 25.14
Smith & Nephew SNATS (SNN) United Kingdom $20.565B 0.00
ResMed (RMD) United States $19.246B 36.70
Sunny Optical Technology (SNPTF) China $16.233B 0.00
Bio-Rad Laboratories (BIO) United States $10.009B 53.66
Canopy Growth (CGC) Canada $9.229B 0.00
Insulet (PODD) United States $8.710B 516.14
Perrigo (PRGO) Ireland $7.614B 14.02
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $7.067B 21.07
Haemonetics (HAE) United States $6.391B 48.23
Aurora Cannabis (ACB) Canada $6.010B 0.00
GN STORE NORD (GNNDY) Denmark $5.608B 28.98
GW Pharmaceuticals (GWPH) United Kingdom $4.399B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $4.046B 67.17
NuVasive (NUVA) United States $3.422B 27.28
ICU Medical (ICUI) United States $3.306B 21.44
Hutchison China MediTech (HCM) China $2.938B 0.00
Quidel (QDEL) United States $2.835B 28.16
National Vision Holdings (EYE) United States $2.466B 53.22
Agios Pharmaceuticals (AGIO) United States $2.241B 0.00
Cardiovascular Systems (CSII) United States $1.803B 0.00
Aphria (APHA) $1.669B 0.00
VAREX IMAGING (VREX) United States $1.137B 26.19
AtriCure (ATRC) United States $0.971B 0.00
Lantheus Holdings (LNTH) United States $0.933B 24.52
Omeros (OMER) United States $0.898B 0.00
Phibro Animal Health (PAHC) United States $0.848B 13.79
Eagle Pharmaceuticals (EGRX) United States $0.809B 20.62
NanoString Technologies (NSTG) United States $0.779B 0.00
PetIQ (PETQ) United States $0.762B 18.01
Cerus (CERS) United States $0.739B 0.00
LeMaitre Vascular (LMAT) United States $0.692B 41.03
MacroGenics (MGNX) United States $0.664B 0.00
Quanterix (QTRX) United States $0.664B 0.00
TG Therapeutics (TGTX) United States $0.644B 0.00
Surmodics (SRDX) United States $0.629B 119.64
OraSure Technologies (OSUR) United States $0.469B 21.70
Owens & Minor (OMI) United States $0.447B 13.40
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.414B 0.00
BioLife Solutions (BLFS) United States $0.372B 122.19
Utah Medical Products (UTMD) United States $0.371B 27.16
United Health Products (UEEC) United States $0.323B 0.00
Zynex (ZYXI) United States $0.278B 29.52
Bovie Medical (APYX) United States $0.255B 0.00
Rockwell Medical (RMTI) United States $0.186B 0.00
Cytosorbents (CTSO) United States $0.172B 0.00
Vapotherm (VAPO) United States $0.165B 0.00
Fonar (FONR) United States $0.151B 7.96
Chimerix (CMRX) United States $0.134B 0.00
Female Health (VERU) United States $0.125B 0.00
Chembio Diagnostics (CEMI) United States $0.113B 0.00
InfuSystems Holdings (INFU) United States $0.104B 0.00
United-Guardian (UG) United States $0.089B 21.05
MRI Interventions (MRIC) United States $0.066B 0.00
Surface Oncology (SURF) United States $0.058B 0.00
Nephros (NEPH) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.052B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.029B 0.00
Senestech (SNES) United States $0.027B 0.00
Myomo (MYO) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
GUARDION HEALTH (GHSI) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00